Rodgers Brothers Inc. Gsk PLC Transaction History

Rodgers Brothers Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$36.52 - $41.46 $559,924 - $635,664	-15,332 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$34.27 - $40.01 $3,427 - $4,001	-100 Reduced 0.65%	15,332 $547,000
Q4 2020 Feb 16, 2021	SELL	$34.07 - $39.94 $393,508 - $461,307	-11,550 Reduced 42.81%	15,432 $568,000
Q3 2020 Nov 13, 2020	SELL	$38.11 - $42.99 $22,866 - $25,794	-600 Reduced 2.18%	26,982 $1.02 Million
Q2 2020 Aug 13, 2020	BUY	$37.87 - $43.58 $1.04 Million - $1.2 Million	27,582 New	27,582 $1.13 Million
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $186,347 - $220,938	-5,273 Closed	0 $0
Q3 2017 Nov 08, 2017	BUY	$39.44 - $41.55 $207,967 - $219,093	5,273	5,273 $214,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Rodgers Brothers Inc., based on Form 13F filings with the SEC.

Stay updated on Rodgers Brothers Inc. with notifications on news.